JP2016517691A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016517691A5 JP2016517691A5 JP2016511126A JP2016511126A JP2016517691A5 JP 2016517691 A5 JP2016517691 A5 JP 2016517691A5 JP 2016511126 A JP2016511126 A JP 2016511126A JP 2016511126 A JP2016511126 A JP 2016511126A JP 2016517691 A5 JP2016517691 A5 JP 2016517691A5
- Authority
- JP
- Japan
- Prior art keywords
- chinese hamster
- sequence
- target polypeptide
- expression cassette
- hamster ovary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 18
- 229920001184 polypeptide Polymers 0.000 claims 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims 14
- 102000004196 processed proteins & peptides Human genes 0.000 claims 14
- 102000016359 Fibronectins Human genes 0.000 claims 12
- 108010067306 Fibronectins Proteins 0.000 claims 12
- 238000000034 method Methods 0.000 claims 10
- 230000028327 secretion Effects 0.000 claims 9
- 102000040430 polynucleotide Human genes 0.000 claims 7
- 108091033319 polynucleotide Proteins 0.000 claims 7
- 239000002157 polynucleotide Substances 0.000 claims 7
- 239000013604 expression vector Substances 0.000 claims 5
- 230000003248 secreting effect Effects 0.000 claims 4
- 108010006025 bovine growth hormone Proteins 0.000 claims 3
- 241000699802 Cricetulus griseus Species 0.000 claims 2
- 108010022394 Threonine synthase Proteins 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 102000004419 dihydrofolate reductase Human genes 0.000 claims 2
- 239000003550 marker Substances 0.000 claims 2
- 101001068154 Bos taurus Hemoglobin subunit beta Proteins 0.000 claims 1
- 108700039887 Essential Genes Proteins 0.000 claims 1
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 claims 1
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 claims 1
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201308017A GB201308017D0 (en) | 2013-05-03 | 2013-05-03 | Expression process |
| GB1308017.1 | 2013-05-03 | ||
| GB201320339A GB201320339D0 (en) | 2013-11-18 | 2013-11-18 | Expression Process |
| GB1320339.3 | 2013-11-18 | ||
| PCT/GB2014/000165 WO2014177826A1 (en) | 2013-05-03 | 2014-04-29 | Expression process |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016517691A JP2016517691A (ja) | 2016-06-20 |
| JP2016517691A5 true JP2016517691A5 (enExample) | 2017-06-08 |
| JP6545153B2 JP6545153B2 (ja) | 2019-07-17 |
Family
ID=50639794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016511126A Active JP6545153B2 (ja) | 2013-05-03 | 2014-04-29 | 発現方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9873891B2 (enExample) |
| EP (1) | EP2992104B1 (enExample) |
| JP (1) | JP6545153B2 (enExample) |
| KR (1) | KR102180660B1 (enExample) |
| CN (2) | CN114395584B (enExample) |
| BR (1) | BR112015027373A2 (enExample) |
| CA (1) | CA2910877C (enExample) |
| DK (1) | DK2992104T3 (enExample) |
| ES (1) | ES2732907T3 (enExample) |
| RU (1) | RU2731717C2 (enExample) |
| SG (1) | SG11201508447TA (enExample) |
| WO (1) | WO2014177826A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3323826A1 (en) * | 2016-11-21 | 2018-05-23 | Danmarks Tekniske Universitet | Native chinese hamster ovary cell secretion signal peptides for production of recombinant polypeptides |
| JP7032438B2 (ja) | 2017-12-11 | 2022-03-08 | 富士フイルム株式会社 | 動物細胞、動物細胞の製造方法および目的タンパク質の製造方法 |
| EP3896168A4 (en) | 2018-12-11 | 2022-03-02 | FUJIFILM Corporation | ANIMAL CELLS, METHODS OF PRODUCTION OF ANIMAL CELLS AND METHODS OF PRODUCTION OF TARGET PROTEIN |
| CN109837277A (zh) * | 2019-03-01 | 2019-06-04 | 深圳生生凡非基因技术有限公司 | 一种cpgk嵌合型启动子、腺相关病毒载体及其应用 |
| WO2021107123A1 (ja) | 2019-11-29 | 2021-06-03 | 富士フイルム株式会社 | 細胞培養方法、抗体製造方法、有機酸除去方法、及び、抗体 |
| EP4276167A1 (en) | 2021-01-07 | 2023-11-15 | FUJIFILM Corporation | Cell selection method, device and device system |
| WO2022196710A1 (ja) | 2021-03-17 | 2022-09-22 | 富士フイルム株式会社 | 細胞培養方法、及び有用物質の製造方法 |
| CN112980852B (zh) * | 2021-05-18 | 2021-08-13 | 北京华芢生物技术有限公司 | 新型冠状病毒b.1.351南非突变株rbd的基因及其应用 |
| JP2024521784A (ja) | 2021-05-27 | 2024-06-04 | ヤンセン バイオテツク，インコーポレーテツド | 前立腺がんの治療のための組成物及び方法 |
| JPWO2023054556A1 (enExample) | 2021-09-30 | 2023-04-06 | ||
| JPWO2023112952A1 (enExample) | 2021-12-15 | 2023-06-22 | ||
| WO2023190300A1 (ja) | 2022-03-28 | 2023-10-05 | 富士フイルム株式会社 | 生産物の生産方法、及び生産物 |
| WO2023190829A1 (ja) | 2022-03-31 | 2023-10-05 | 富士フイルム株式会社 | 生産物の製造方法、及び生産物 |
| WO2023238949A1 (ja) | 2022-06-10 | 2023-12-14 | 富士フイルム株式会社 | 細胞の作出方法、ヘテロ多量体タンパク質の製造方法、バイスペシフィック抗体の製造方法、ベクターセット、哺乳動物細胞、ｃｈｏ細胞、及び細胞プールの作出方法 |
| JPWO2024071373A1 (enExample) | 2022-09-29 | 2024-04-04 | ||
| WO2025244971A1 (en) | 2024-05-20 | 2025-11-27 | Janssen Biotech, Inc. | Compositions and methods for the treatment of prostate cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003223766A1 (en) * | 2002-04-30 | 2003-11-17 | University Of North Carolina At Chapel Hill | Secretion signal vectors |
| US7186699B2 (en) * | 2003-06-03 | 2007-03-06 | Cell Genesys, Inc. | Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| US8029783B2 (en) * | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
| EP1739179A1 (en) * | 2005-06-30 | 2007-01-03 | Octapharma AG | Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| GB0602173D0 (en) * | 2006-02-03 | 2006-03-15 | Avecia Ltd | Expression system |
| CN101646775B (zh) * | 2006-12-28 | 2016-08-24 | 森托科尔奥索生物科技公司 | 用于产生脱唾液酸化免疫球蛋白的方法和载体 |
| KR101618767B1 (ko) * | 2008-09-02 | 2016-05-09 | 한국생명공학연구원 | 외래단백질을 고효율로 생산하는 리더서열 |
| CN102272160A (zh) * | 2008-12-31 | 2011-12-07 | 印度血清及疫苗有限公司 | 抗rhd单克隆抗体 |
| PE20160653A1 (es) | 2009-03-05 | 2016-07-24 | Abbvie Inc | Proteinas de union a il-17 |
| GB0905331D0 (en) * | 2009-03-27 | 2009-05-13 | Avecia Biolog Ltd | Expression process |
| KR101420274B1 (ko) * | 2011-06-13 | 2014-07-21 | 주식회사 종근당 | Ｃｓｐ－ｂ ５＇ｓａｒ 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법 |
-
2014
- 2014-04-29 ES ES14721474T patent/ES2732907T3/es active Active
- 2014-04-29 WO PCT/GB2014/000165 patent/WO2014177826A1/en not_active Ceased
- 2014-04-29 BR BR112015027373A patent/BR112015027373A2/pt not_active Application Discontinuation
- 2014-04-29 JP JP2016511126A patent/JP6545153B2/ja active Active
- 2014-04-29 EP EP14721474.6A patent/EP2992104B1/en active Active
- 2014-04-29 KR KR1020157032562A patent/KR102180660B1/ko active Active
- 2014-04-29 US US14/787,669 patent/US9873891B2/en active Active
- 2014-04-29 DK DK14721474.6T patent/DK2992104T3/da active
- 2014-04-29 CN CN202111508425.XA patent/CN114395584B/zh active Active
- 2014-04-29 CA CA2910877A patent/CA2910877C/en active Active
- 2014-04-29 CN CN201480024993.4A patent/CN105392889A/zh active Pending
- 2014-04-29 RU RU2015151626A patent/RU2731717C2/ru active
- 2014-04-29 SG SG11201508447TA patent/SG11201508447TA/en unknown
-
2017
- 2017-12-12 US US15/838,868 patent/US11306323B2/en active Active
-
2022
- 2022-03-15 US US17/694,760 patent/US20220213500A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016517691A5 (enExample) | ||
| RU2015151626A (ru) | Способ экспрессии | |
| PH12020551039A1 (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| JP2010536396A5 (enExample) | ||
| HK1207575A1 (en) | Bispecific asymmetric heterodimers comprising anti-cd3 constructs | |
| EA202092093A1 (ru) | Композиции и способы перепрограммирования tcr с применением слитых белков | |
| HRP20201153T1 (hr) | Pd-1 sredstva visokog afiniteta i načini uporabe | |
| JP2015529826A5 (enExample) | ||
| EA202090931A3 (ru) | Композиции и способы перепрограммирования tcr с помощью гибридных белков | |
| HRP20191865T1 (hr) | Novi heterodimerni proteini | |
| BR112012018914A2 (pt) | "anticorpo humanizado, proteína de ligação de antígeno, molécula de ácido nucleico, vetor de expressão, célula hospedeira recombinante, proteína de ligação de anticorpo ou de antígeno, métodos para a produção de uma proteína de ligação de antígeno e para tratar um sujeito afetado por uma doença autoimune ou inflamatória, e, composição farmacêutica." | |
| BR112017005245A2 (pt) | animal não humano geneticamente modificado, métodos para produzir célula t, hibridoma de célula t, um ácido nucleico, um anticorpo específico, uma célula humana, um animal não humano geneticamente modificado e para induzir uma resposta imunológica, célula, hibridoma de célula t, ácido nucleico, anticorpo específico, receptor de antígeno quimérico, embrião não humano, locus de um receptor de antígeno quimérico, e, composição de ácidos nucleicos. | |
| HK1243333A1 (zh) | 用於修饰的t细胞的方法和组合物 | |
| JP2015519055A5 (enExample) | ||
| AR063683A1 (es) | Anticuerpos para il-17a | |
| RU2014118869A (ru) | Мыши с ограниченной тяжелой цепью иммуноглобулина | |
| WO2009091912A3 (en) | Improved mammalian expression vectors and uses thereof | |
| MY172718A (en) | Humanized universal light chain mice | |
| BRPI0812091A2 (pt) | Método para fabricar uma proteína policlonal recombinante | |
| MX376623B (es) | Cultivo celular metabolicamente optimizado. | |
| WO2013039996A4 (en) | Compositions and methods for brown fat induction and activity using fndc5 | |
| RU2016136855A (ru) | Биомаркер-направленная многоцелевая иммунотерапия | |
| JP2013539369A5 (enExample) | ||
| WO2018102787A9 (en) | Methods for determining car-t cells dosing | |
| PH12022551580A1 (en) | Anti-ctla-4 antibody and use thereof |